ObsEva

$3.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-2.56%) Today

+$0.01 (+0.33%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ObsEva and other stocks, options, and ETFs commission-free!

About OBSV

ObsEva SA Ordinary Shares, also called ObsEva, is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for woman's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth.

CEO

Brian O'Callaghan

Employees

Headquarters

Geneva, Geneve (Geneva)

Founded

2012

Market Cap

265.71M

Price-Earnings Ratio

—

Dividend Yield

0.00

Average Volume

860.58K

High Today

$3.14

Low Today

$3.03

Open Price

$3.11

Volume

701.12K

52 Week High

$6.30

52 Week Low

$1.86

Analyst Ratings

67%

of 6 ratings

Buy

67%

Hold

17%

Sell

17%

OBSV Earnings

-$0.63

-$0.42

-$0.21

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 4, Pre-Market